Ionis Pharmaceuticals (IONS) PT Lowered to $85 at Barclays

September 9, 2026 5:06 AM

Barclays analyst Eliana Merle lowered the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $85.00 (from $90.00) while maintaining a Overweight rating.

No results found